Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins.

Biotechnology

AbSci

AbSci's headquarters in Vancouver, WA, United States

Sean McClain

Wen Sha

Chad Taylor

Yukte Sharma- Dayal

Senior Scientist

Karin Wierinck

Andreas Busch

Nikhil Goel

Zachariah Jonasson

Gustavo Mahler

V. Bryan Lawlis

Dan Gold

Andy Pihl

The Leadership Team at AbSci drives strategic decision-making and sets the vision for the company, ensuring alignment between drug and target discovery initiatives and business objectives. Comprising experts in immunology, process development, synthetic biology, informatics, and accounting, the team leverages diverse insights to optimize innovation in therapeutic protein development, while navigating the complexities of synthetic biology and AI technologies.

Leadership Team

The Research and Development team at AbSci focuses on leveraging advanced deep learning AI and synthetic biology techniques to innovate and enhance drug discovery processes. This team collaborates on developing novel therapeutic proteins, conducting translational research, and driving projects from initial concept through to proof-of-concept stages, ensuring the efficient transition from research to clinical application.

Research and Development

The AI and Data Science Team at AbSci specializes in leveraging advanced deep learning algorithms and data analytics to enhance drug and target discovery processes. This team collaborates closely with synthetic biology experts to optimize protein therapeutic potentials, driving innovations that accelerate the development of next-generation biopharmaceuticals. Their expertise in artificial intelligence empowers data-driven decision-making, ultimately improving research outcomes and therapeutic efficacy.

AI and Data Science Team

The Business Development and Strategy team at AbSci focuses on identifying and cultivating strategic partnerships and collaborations that enhance the company’s growth and innovation in drug and target discovery. Leveraging expertise in portfolio management and market trends, the team drives strategic initiatives, negotiates alliances, and develops pathways to commercialize AbSci's cutting-edge protein therapeutics, ultimately advancing their mission of harnessing AI and synthetic biology for transformative healthcare solutions.

Business Development and Strategy

The Research and Development team at AbSci is dedicated to advancing therapeutic innovations by integrating synthetic biology with deep learning AI. This team focuses on drug and target discovery, utilizing expertise in protein engineering, analytics, and informatics to optimize the development process and enhance the efficacy of new therapeutics.

AbSci

Org chart

Board & advisors

Teams

Leadership Team

Research and Development

AI and Data Science Team

Business Development and Strategy

Research and Development

Offices

Similar companies